Can plant extracts help tame blood sugar in prediabetes?
NCT ID NCT05926947
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests two plant-based supplement blends in 87 overweight adults with prediabetes. Over 12 weeks, researchers measure changes in blood sugar markers like HbA1c and post-meal glucose. The goal is to see if these natural extracts can help manage blood sugar levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- plant extracts (polyphenols from olive leaf, blackcurrant, pomegranate, grapefruit, white kidney bean, plus chromium and zinc)
- What this could lead to
- If it works, this could point toward a natural supplement option to help manage blood sugar in people with prediabetes.
- What could go wrong
- This is a small early-stage proof-of-concept study, not a large definitive trial. The supplements may not significantly lower blood sugar, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 87 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2023
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Fasting Plasma Glucose 75 - 125 mg/dL * HbA1c: 5.-6.5 % * Both sexes * Overweight BMI range (25-30 Kg/m2) * Age: 20-50 years old Exclusion Criteria: * Metabolic/Chronical disease * Menopausal women * Being pregnant, breastfeeding or wanting to have a baby * Former obese with a history of yoyo effect * Have been involved in a weight loss program in the past 12 months or subjected to weight reduction surgery * Having started or quit smoking, having a high alcohol consumption * Have in the past been in a long-term antibiotherapy (1 month or more) and/or a regular antibiotherapy in the past 12 months * Allergy to olive, blackcurrant, pomegranate, grapefruit, white kidney bean, or corn.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Overweight are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCAM Universidad Católica San Antonio de Murcia
Guadalupe, Murcia, 30107, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vegan diet shield police officers from heart disease?
- Can 10-Minute school break videos get overweight kids moving?
- Weekly shot aims to melt away pounds in obesity fight
- Can meal timing change how well a Weight-Loss pill works?
- Can a new injection help tackle obesity? a trial puts it to the test
- Can an obesity drug weaken birth control? a trial investigates